semaglutide and anorexia Post-Ozempic society is here Beyond Weight Loss: GLP-1 Usage

Health Canada has received nine applications from five named companies to sell duplicates of semaglutide, the active ingredient in Ozempic, which is marketed for Type 2 diabetes, and Wegovy, a higher-dose version approved specifically for weight loss

doi: 10.1111/tpj.14161 60 Winkel-ShirleyB

But beyond red meats which should be limited for other reasons, Seides says its too soon to recommend that people stop consuming foods containing carnitine

Springer Verlag

The N-terminus of ghrelin inserts deep in the helix bundle

Strutynska N, Goshovska Y, Mys L, Strutynskyi R, Luchkova A, Fedichkina R, Okhai I, Korkach Y, Sagach V